Main Menu

Target Discovery and Apoptosis Team

Dr Spiros Linardopoulos's laboratory aims to identify and validate new molecular targets and to develop drugs through the process of hit generation, lead identification/optimisation and candidate selection. It also aims to identify tumour types and patient subgroups that would benefit from specific treatments. Dr Linardopoulos's programme encompasses both basic research and drug discovery components.

Team leader

Professor Spiros Linardopoulos

Professor Spiros Linardopoulos

Professor Spiros Linardopoulos is searching for gene targets for which new anticancer drugs can be developed and which identify patient subgroups that would benefit from treatment. He is a member of several professional organisations, including the Greek Chemical Society and the Hellenic Biochemical and Biophysical Society, and a key member of the Cancer Research UK Cancer Therapeutics Unit.

T 020 7153 5341

Team members

Dr Katrin Gutsche

Post-doctoral Training Fellow

Dr Grace Mak

Senior Scientific Officer

Dr Lisa O’Fee

Higher Scientific Officer

Dr Yiannis Poursaitidis

Post-doctoral Training Fellow